Target intelligence / Profile preview

Paracrine Signaling Pathways and Extracellular Matrix Environment

Molecular classification
Other
01

Overview

Paracrine Signaling Pathways and Extracellular Matrix (ECM) Environment refers to the integrated system of local cellular communication and the non-cellular structural framework that regulates tissue physiology. Paracrine signaling involves the secretion of molecules such as growth factors, cytokines, and chemokines that act on nearby cells to coordinate development, immunity, and repair (Alberts et al., 2002). The ECM provides the physical scaffolding for cells while simultaneously acting as a reservoir for these signaling molecules and transmitting mechanical cues through receptors like integrins (Hynes, 2009). In pathological conditions like cancer and chronic fibrosis, these pathways and the ECM architecture become severely dysregulated, forming a 'reactive stroma' that promotes uncontrolled cell growth, metastasis, and resistance to therapy (Lu et al., 2012). While this entry describes a broad biological context rather than a single molecular target, specific individual components within this environment—such as Vascular Endothelial Growth Factor (VEGF) or Transforming Growth Factor-beta (TGF-β)—are major focuses of drug development (Quail & Joyce, 2013). Targeted therapies often aim to disrupt these local signaling loops or degrade excessive ECM components to restore normal tissue function or enhance the delivery of other medications.

Other names
Tissue microenvironmentTumor microenvironmentCell-ECM signalingStroma-epithelial interactionParacrine signaling
02

Mechanism of action

Modulation of growth factor availability, inhibition of extracellular matrix remodeling enzymes (e.g., MMPs), blockade of integrin-mediated cell adhesion, or neutralization of paracrine ligands.

03

Biological functions

Signal transductionCell adhesionTissue homeostasisCell migrationWound healingCell proliferation
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseMetabolic disorders
05

Safety considerations

Impaired systemic wound healingDisruption of normal tissue homeostasisPotential for paradoxical pro-fibrotic responsesOff-target effects on healthy stromal compartments
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinase (MMP) levelsCollagen degradation products (e.g., Pro-C3)TGF-beta expression levelsVEGF concentrationECM stiffness

Beyond the preview

Go deeper on Paracrine Signaling Pathways and Extracellular Matrix Environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine Signaling Pathways and Extracellular Matrix Environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call